Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melphalan | 38 | 2023 | 431 | 3.560 |
Why?
|
Amyloidosis | 29 | 2023 | 795 | 2.270 |
Why?
|
Blood Transfusion | 8 | 2018 | 1301 | 2.010 |
Why?
|
Blood Donors | 5 | 2013 | 355 | 1.570 |
Why?
|
Isoantibodies | 4 | 2018 | 679 | 1.380 |
Why?
|
ABO Blood-Group System | 4 | 2013 | 367 | 1.350 |
Why?
|
Blood Group Incompatibility | 4 | 2012 | 146 | 1.330 |
Why?
|
Donor Selection | 3 | 2013 | 201 | 1.100 |
Why?
|
Plasma | 3 | 2013 | 575 | 1.020 |
Why?
|
Stem Cell Transplantation | 17 | 2020 | 1620 | 0.960 |
Why?
|
Hemolysis | 3 | 2011 | 420 | 0.890 |
Why?
|
Granulocytes | 3 | 2009 | 548 | 0.880 |
Why?
|
Plateletpheresis | 3 | 2011 | 47 | 0.840 |
Why?
|
Blood Protein Electrophoresis | 1 | 2021 | 73 | 0.820 |
Why?
|
Hemoglobins, Abnormal | 1 | 2021 | 119 | 0.790 |
Why?
|
Hydrops Fetalis | 1 | 2021 | 107 | 0.770 |
Why?
|
Antineoplastic Agents, Alkylating | 11 | 2020 | 627 | 0.730 |
Why?
|
Platelet Transfusion | 3 | 2016 | 314 | 0.720 |
Why?
|
Hematopoietic Stem Cell Transplantation | 18 | 2023 | 5445 | 0.720 |
Why?
|
Blood Component Transfusion | 2 | 2013 | 143 | 0.710 |
Why?
|
Factor VIIa | 2 | 2012 | 101 | 0.680 |
Why?
|
Love | 1 | 2018 | 37 | 0.650 |
Why?
|
Leukapheresis | 2 | 2018 | 131 | 0.650 |
Why?
|
Hematopoietic Stem Cell Mobilization | 4 | 2014 | 227 | 0.640 |
Why?
|
Granulocyte Colony-Stimulating Factor | 3 | 2014 | 648 | 0.640 |
Why?
|
Plasmapheresis | 1 | 2018 | 211 | 0.600 |
Why?
|
Immunoglobulin Light Chains | 9 | 2020 | 277 | 0.590 |
Why?
|
Tranexamic Acid | 1 | 2018 | 146 | 0.570 |
Why?
|
Blood Grouping and Crossmatching | 3 | 2012 | 108 | 0.550 |
Why?
|
Anemia, Sickle Cell | 4 | 2016 | 1020 | 0.540 |
Why?
|
Transplantation, Autologous | 19 | 2023 | 2123 | 0.530 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 5 | 2019 | 272 | 0.480 |
Why?
|
Transplantation Conditioning | 8 | 2019 | 1599 | 0.480 |
Why?
|
Bombs | 1 | 2014 | 72 | 0.460 |
Why?
|
Myeloablative Agonists | 7 | 2019 | 218 | 0.440 |
Why?
|
Heterocyclic Compounds | 1 | 2014 | 248 | 0.440 |
Why?
|
Dexamethasone | 3 | 2019 | 1950 | 0.420 |
Why?
|
Erythrocytes | 3 | 2012 | 2455 | 0.420 |
Why?
|
Anemia, Hemolytic | 1 | 2012 | 168 | 0.400 |
Why?
|
Blast Injuries | 1 | 2014 | 302 | 0.370 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2010 | 65 | 0.370 |
Why?
|
Hematologic Tests | 2 | 2011 | 240 | 0.340 |
Why?
|
Medical Errors | 2 | 2009 | 1297 | 0.340 |
Why?
|
Graft Survival | 3 | 2018 | 3734 | 0.330 |
Why?
|
Adrenal Cortex Hormones | 1 | 2018 | 1854 | 0.330 |
Why?
|
Blood Banks | 3 | 2016 | 111 | 0.330 |
Why?
|
Chorioamnionitis | 1 | 2009 | 155 | 0.320 |
Why?
|
Anemia, Aplastic | 1 | 2009 | 226 | 0.310 |
Why?
|
Sports | 1 | 2014 | 688 | 0.300 |
Why?
|
Blood Specimen Collection | 1 | 2009 | 246 | 0.300 |
Why?
|
Blood Component Removal | 2 | 2000 | 125 | 0.300 |
Why?
|
Ceftriaxone | 1 | 2008 | 168 | 0.300 |
Why?
|
Medication Adherence | 1 | 2018 | 2063 | 0.290 |
Why?
|
Factor VII | 1 | 2007 | 139 | 0.290 |
Why?
|
Education, Medical | 1 | 2018 | 1722 | 0.280 |
Why?
|
Acute Lung Injury | 1 | 2010 | 380 | 0.280 |
Why?
|
Patient Identification Systems | 1 | 2006 | 79 | 0.270 |
Why?
|
Phlebotomy | 1 | 2006 | 141 | 0.260 |
Why?
|
Probiotics | 1 | 2009 | 350 | 0.260 |
Why?
|
HLA Antigens | 1 | 2010 | 1382 | 0.250 |
Why?
|
Graft Rejection | 1 | 2018 | 4398 | 0.250 |
Why?
|
Wounds and Injuries | 3 | 2013 | 2401 | 0.250 |
Why?
|
Plasma Exchange | 2 | 2017 | 152 | 0.250 |
Why?
|
High-Throughput Screening Assays | 1 | 2010 | 944 | 0.240 |
Why?
|
Blood Coagulation Disorders | 1 | 2007 | 337 | 0.230 |
Why?
|
Middle Aged | 51 | 2021 | 213241 | 0.230 |
Why?
|
Kidney Transplantation | 2 | 2018 | 4251 | 0.230 |
Why?
|
Fetal Blood | 1 | 2009 | 1318 | 0.220 |
Why?
|
Cell Separation | 1 | 2008 | 1750 | 0.220 |
Why?
|
Antibodies | 1 | 2011 | 2459 | 0.210 |
Why?
|
Remission Induction | 4 | 2019 | 2384 | 0.210 |
Why?
|
Hematopoietic Stem Cells | 2 | 2014 | 3389 | 0.210 |
Why?
|
Male | 51 | 2021 | 349776 | 0.200 |
Why?
|
Humans | 78 | 2023 | 743811 | 0.200 |
Why?
|
Specimen Handling | 1 | 2006 | 694 | 0.200 |
Why?
|
Aged | 39 | 2022 | 163178 | 0.200 |
Why?
|
Histiocytes | 1 | 2021 | 103 | 0.190 |
Why?
|
Adult | 42 | 2021 | 213889 | 0.190 |
Why?
|
Female | 54 | 2021 | 380020 | 0.190 |
Why?
|
Abducens Nerve Diseases | 1 | 2021 | 43 | 0.190 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4561 | 0.190 |
Why?
|
Plasmacytoma | 1 | 2021 | 183 | 0.180 |
Why?
|
HTLV-II Infections | 1 | 2019 | 4 | 0.180 |
Why?
|
Renal Dialysis | 4 | 2017 | 1783 | 0.180 |
Why?
|
Autoantibodies | 1 | 2008 | 2037 | 0.170 |
Why?
|
HTLV-I Infections | 1 | 2019 | 101 | 0.170 |
Why?
|
Defibrillators | 1 | 2019 | 37 | 0.170 |
Why?
|
Pulmonary Alveoli | 1 | 2021 | 674 | 0.160 |
Why?
|
Kidney Diseases | 4 | 2023 | 2146 | 0.160 |
Why?
|
Brachial Plexus Neuritis | 1 | 2017 | 20 | 0.160 |
Why?
|
Skull Base Neoplasms | 1 | 2021 | 284 | 0.150 |
Why?
|
Survival Analysis | 9 | 2020 | 10251 | 0.150 |
Why?
|
Blood Safety | 1 | 2016 | 14 | 0.150 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 260 | 0.140 |
Why?
|
Splenic Rupture | 1 | 2015 | 26 | 0.140 |
Why?
|
Thrombotic Microangiopathies | 1 | 2017 | 132 | 0.130 |
Why?
|
Hemothorax | 1 | 1995 | 60 | 0.130 |
Why?
|
Multiple Myeloma | 3 | 2021 | 5185 | 0.130 |
Why?
|
Hypoalbuminemia | 1 | 2016 | 86 | 0.130 |
Why?
|
Hypotension | 1 | 2000 | 884 | 0.120 |
Why?
|
Thrombasthenia | 1 | 2013 | 24 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2000 | 1516 | 0.120 |
Why?
|
Time Factors | 9 | 2018 | 40038 | 0.120 |
Why?
|
Benzylamines | 1 | 2014 | 223 | 0.110 |
Why?
|
Risk Management | 1 | 2016 | 571 | 0.110 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2012 | 188 | 0.100 |
Why?
|
Blood Platelets | 3 | 2013 | 2509 | 0.100 |
Why?
|
Military Medicine | 1 | 2013 | 176 | 0.100 |
Why?
|
Erythrocyte Transfusion | 1 | 2016 | 565 | 0.100 |
Why?
|
Heparin | 1 | 2018 | 1637 | 0.100 |
Why?
|
Portugal | 1 | 2010 | 86 | 0.090 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2012 | 339 | 0.090 |
Why?
|
Treatment Outcome | 19 | 2020 | 63042 | 0.090 |
Why?
|
Liver Diseases | 2 | 2009 | 1253 | 0.090 |
Why?
|
Paraproteinemias | 2 | 2010 | 246 | 0.090 |
Why?
|
Catheterization, Central Venous | 1 | 1995 | 514 | 0.090 |
Why?
|
Thrombocytopenia | 1 | 2018 | 1178 | 0.090 |
Why?
|
Heart Failure | 1 | 2014 | 10896 | 0.090 |
Why?
|
Infant, Newborn | 3 | 2021 | 25609 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3175 | 0.090 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2013 | 220 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 1377 | 0.090 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4777 | 0.090 |
Why?
|
Running | 1 | 2014 | 479 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2017 | 10940 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 3874 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6539 | 0.080 |
Why?
|
Disease-Free Survival | 4 | 2017 | 6895 | 0.080 |
Why?
|
Tissue Donors | 1 | 2018 | 2241 | 0.080 |
Why?
|
Plaque, Amyloid | 1 | 2012 | 729 | 0.080 |
Why?
|
Pregnancy Trimester, Third | 1 | 2010 | 571 | 0.080 |
Why?
|
Disaster Planning | 1 | 2014 | 548 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6487 | 0.080 |
Why?
|
Hypergammaglobulinemia | 1 | 2007 | 74 | 0.080 |
Why?
|
Pregnancy Trimester, Second | 1 | 2010 | 732 | 0.080 |
Why?
|
Cell Size | 1 | 2009 | 641 | 0.080 |
Why?
|
Bone Marrow | 2 | 2020 | 2951 | 0.070 |
Why?
|
Patient Care Team | 2 | 2017 | 2528 | 0.070 |
Why?
|
Boronic Acids | 1 | 2011 | 965 | 0.070 |
Why?
|
Clinical Protocols | 1 | 2013 | 1459 | 0.070 |
Why?
|
alpha-Thalassemia | 1 | 2007 | 46 | 0.070 |
Why?
|
Vascular Diseases | 1 | 1995 | 1161 | 0.070 |
Why?
|
Antisickling Agents | 1 | 2007 | 80 | 0.070 |
Why?
|
Aging | 2 | 2021 | 8655 | 0.070 |
Why?
|
Aged, 80 and over | 12 | 2021 | 57744 | 0.070 |
Why?
|
Mycoses | 1 | 2009 | 376 | 0.070 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2006 | 87 | 0.070 |
Why?
|
Pregnancy Trimester, First | 1 | 2010 | 853 | 0.070 |
Why?
|
Brazil | 1 | 2010 | 1264 | 0.070 |
Why?
|
Reticulocytes | 1 | 2007 | 290 | 0.070 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2006 | 173 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6750 | 0.070 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2012 | 691 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2014 | 1411 | 0.070 |
Why?
|
Lung | 2 | 2021 | 9858 | 0.070 |
Why?
|
Hodgkin Disease | 1 | 2013 | 1415 | 0.070 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 1392 | 0.070 |
Why?
|
Hydroxyurea | 1 | 2007 | 289 | 0.070 |
Why?
|
Pyrazines | 1 | 2011 | 1230 | 0.060 |
Why?
|
International Normalized Ratio | 1 | 2007 | 367 | 0.060 |
Why?
|
Survival Rate | 6 | 2011 | 12786 | 0.060 |
Why?
|
Chronic Disease | 2 | 2018 | 9139 | 0.060 |
Why?
|
Cell Adhesion | 1 | 2012 | 3144 | 0.060 |
Why?
|
Factor X Deficiency | 2 | 2001 | 9 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3839 | 0.060 |
Why?
|
Leukocyte Count | 1 | 2008 | 1588 | 0.060 |
Why?
|
Leukemia, T-Cell | 1 | 2004 | 104 | 0.060 |
Why?
|
Hospitals, University | 1 | 2006 | 570 | 0.060 |
Why?
|
Hemoglobin, Sickle | 1 | 2004 | 122 | 0.060 |
Why?
|
Thrombosis | 1 | 2018 | 2968 | 0.060 |
Why?
|
Fever | 2 | 2009 | 1616 | 0.060 |
Why?
|
Combined Modality Therapy | 6 | 2017 | 8637 | 0.060 |
Why?
|
Quality Control | 1 | 2006 | 841 | 0.060 |
Why?
|
Recurrence | 2 | 2017 | 8337 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2013 | 2107 | 0.060 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39001 | 0.060 |
Why?
|
Antineoplastic Agents | 4 | 2019 | 13691 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9239 | 0.050 |
Why?
|
Pericardial Effusion | 1 | 2004 | 247 | 0.050 |
Why?
|
Boston | 2 | 2014 | 9310 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3134 | 0.050 |
Why?
|
Kidney | 1 | 2018 | 7185 | 0.050 |
Why?
|
Heart Diseases | 2 | 2013 | 2789 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1917 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
HIV Infections | 1 | 2008 | 16715 | 0.050 |
Why?
|
Retrospective Studies | 11 | 2019 | 77410 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2009 | 15067 | 0.050 |
Why?
|
Alkylating Agents | 1 | 2001 | 139 | 0.050 |
Why?
|
Mortality | 1 | 2012 | 2862 | 0.050 |
Why?
|
Bacterial Infections | 1 | 2009 | 1400 | 0.050 |
Why?
|
Fatal Outcome | 2 | 2020 | 1851 | 0.050 |
Why?
|
Heart Transplantation | 1 | 2014 | 3113 | 0.050 |
Why?
|
Bradykinin | 1 | 2000 | 214 | 0.050 |
Why?
|
Cranial Fossa, Posterior | 1 | 2021 | 139 | 0.050 |
Why?
|
Filtration | 1 | 2000 | 233 | 0.040 |
Why?
|
Liver | 2 | 2020 | 7479 | 0.040 |
Why?
|
Prospective Studies | 4 | 2015 | 53250 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2017 | 5033 | 0.040 |
Why?
|
Pregnancy | 2 | 2010 | 29140 | 0.040 |
Why?
|
Hyperplasia | 1 | 2021 | 1185 | 0.040 |
Why?
|
Amyloid | 3 | 2009 | 795 | 0.040 |
Why?
|
Adolescent | 4 | 2010 | 85729 | 0.040 |
Why?
|
Paraproteins | 1 | 2017 | 39 | 0.040 |
Why?
|
Virus Activation | 1 | 2019 | 319 | 0.040 |
Why?
|
Anticoagulants | 1 | 2012 | 4599 | 0.040 |
Why?
|
Hemorrhage | 2 | 2007 | 3458 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6620 | 0.040 |
Why?
|
Autopsy | 1 | 2020 | 1020 | 0.040 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 552 | 0.040 |
Why?
|
Child | 3 | 2016 | 77637 | 0.030 |
Why?
|
Genotype | 1 | 2010 | 12944 | 0.030 |
Why?
|
Polyradiculoneuropathy | 1 | 1995 | 64 | 0.030 |
Why?
|
Pharmacists | 1 | 2017 | 248 | 0.030 |
Why?
|
Genetic Variation | 1 | 2010 | 6535 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 11524 | 0.030 |
Why?
|
Hospitalization | 1 | 2014 | 10259 | 0.030 |
Why?
|
Hematology | 1 | 2017 | 221 | 0.030 |
Why?
|
Spleen | 1 | 2020 | 2359 | 0.030 |
Why?
|
United States | 2 | 2013 | 69859 | 0.030 |
Why?
|
Physical Therapy Modalities | 1 | 2017 | 549 | 0.030 |
Why?
|
Young Adult | 2 | 2010 | 56392 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2012 | 19894 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2023 | 2267 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2020 | 3476 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2010 | 9272 | 0.030 |
Why?
|
Cohort Studies | 2 | 2017 | 40545 | 0.030 |
Why?
|
Bleomycin | 1 | 2013 | 512 | 0.030 |
Why?
|
Leukocytes | 1 | 2000 | 2044 | 0.030 |
Why?
|
Vinblastine | 1 | 2013 | 501 | 0.030 |
Why?
|
Dacarbazine | 1 | 2013 | 566 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3758 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2017 | 1275 | 0.020 |
Why?
|
Sample Size | 1 | 2013 | 841 | 0.020 |
Why?
|
Troponin I | 1 | 2013 | 619 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 1738 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 2009 | 354 | 0.020 |
Why?
|
Reticulocyte Count | 1 | 2007 | 37 | 0.020 |
Why?
|
Doxorubicin | 1 | 2013 | 2234 | 0.020 |
Why?
|
Angiography | 1 | 2012 | 1638 | 0.020 |
Why?
|
Child, Preschool | 1 | 2009 | 40964 | 0.020 |
Why?
|
Quality of Life | 2 | 2006 | 12788 | 0.020 |
Why?
|
Histiocytosis | 1 | 2006 | 40 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1800 | 0.020 |
Why?
|
Protein Subunits | 1 | 2009 | 959 | 0.020 |
Why?
|
Infant | 1 | 2008 | 35122 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2727 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14714 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2013 | 1572 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10477 | 0.020 |
Why?
|
Heart | 1 | 2019 | 4460 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12354 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2021 | 6237 | 0.020 |
Why?
|
Patient Dropouts | 1 | 2007 | 420 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2534 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 21733 | 0.020 |
Why?
|
Radiography | 1 | 2015 | 7010 | 0.020 |
Why?
|
Pilot Projects | 2 | 2011 | 8316 | 0.010 |
Why?
|
Globins | 1 | 2004 | 416 | 0.010 |
Why?
|
Cardiac Tamponade | 1 | 2004 | 173 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8660 | 0.010 |
Why?
|
Body Fluids | 1 | 2004 | 319 | 0.010 |
Why?
|
Incidence | 2 | 2017 | 20948 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2005 | 658 | 0.010 |
Why?
|
Dimerization | 1 | 2004 | 894 | 0.010 |
Why?
|
Erythropoiesis | 1 | 2007 | 706 | 0.010 |
Why?
|
Cause of Death | 1 | 2012 | 3580 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 7729 | 0.010 |
Why?
|
Risk Factors | 1 | 2009 | 72252 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2004 | 1574 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.010 |
Why?
|
Blood Coagulation Tests | 1 | 2001 | 263 | 0.010 |
Why?
|
Case Management | 1 | 2001 | 286 | 0.010 |
Why?
|
Point Mutation | 1 | 2004 | 1623 | 0.010 |
Why?
|
Prednisone | 1 | 2004 | 1574 | 0.010 |
Why?
|
Multiple Organ Failure | 1 | 2001 | 389 | 0.010 |
Why?
|
Nephrotic Syndrome | 1 | 2001 | 389 | 0.010 |
Why?
|
Kinetics | 1 | 2005 | 6476 | 0.010 |
Why?
|
Survivors | 1 | 2007 | 2291 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2001 | 2274 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2001 | 1676 | 0.010 |
Why?
|
Recovery of Function | 1 | 2006 | 2922 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2012 | 20121 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2004 | 2566 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2009 | 11360 | 0.010 |
Why?
|
Cytokines | 1 | 2009 | 7324 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2004 | 5973 | 0.010 |
Why?
|
Health Surveys | 1 | 2004 | 4036 | 0.010 |
Why?
|
Prognosis | 1 | 2013 | 29052 | 0.010 |
Why?
|
Oxygen | 1 | 2004 | 4189 | 0.010 |
Why?
|
Neutrophils | 1 | 2005 | 3718 | 0.010 |
Why?
|
Forecasting | 1 | 2001 | 2950 | 0.010 |
Why?
|
Echocardiography | 1 | 2004 | 5096 | 0.010 |
Why?
|
Sex Factors | 1 | 2005 | 10394 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2001 | 2760 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 2001 | 1911 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 12954 | 0.010 |
Why?
|
Patient Selection | 1 | 2001 | 4210 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2004 | 13980 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 2001 | 7908 | 0.000 |
Why?
|